RxDoctor Payments DataLook up a doctor →

Angela Clark, APRN

Primary Care · Bowling Green, KYNPI 1346776390

Payments from drug & device makers

$9,939in general payments, 2019–2025

Across 793 payments — averaging $12.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Pfizer$1K
  • AstraZeneca$695
  • Amgen$346
  • Biohaven Pharmaceuticals, Inc.$312
  • Biohaven Pharmaceutical Holding Company Ltd.$298
  • plus $4K from 47 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie394$3,696
Pfizer107$1,031
AstraZeneca9$695
Amgen28$346
Biohaven Pharmaceuticals, Inc.36$312
Biohaven Pharmaceutical Holding Company Ltd.40$298
Lilly USA, LLC11$287
Axsome Therapeutics, Inc.18$283
Biogen19$267
Harmony Biosciences LLC8$210
Jazz Pharmaceuticals Inc.3$188
Novartis11$175
Johnson & Johnson11$171
Mallinckrodt Hospital Products Inc.3$147
Sanofi-aventis U.S. LLC7$131
Baxter Healthcare6$127
Boehringer Ingelheim8$126
Lundbeck LLC6$111
Grifols USA, LLC8$110
Actelion Pharmaceuticals US, Inc.2$105
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$95
Irhythm Technologies, Inc.1$95
GSK5$88
Teva Pharmaceuticals USA, Inc.3$77
UCB, Inc.4$65
Novo Nordisk4$63
Otsuka America Pharmaceutical, Inc.2$39
Neurocrine Biosciences, Inc.2$37
Adamas Pharmaceuticals, Inc.2$36
Amneal Pharmaceuticals LLC2$33
Merck2$33
Bayer2$33
Abiomed1$32
Philips North America LLC2$31
E.r. Squibb & Sons, L.L.C.2$29
Dexcom, Inc.2$29
Catalyst Pharmaceuticals, Inc.1$29
Supernus Pharmaceuticals, Inc.1$24
Cardiva Medical, Inc.1$23
Exact Sciences1$23
Shield Therapeutics Inc1$23
Phadia US Inc.1$21
Astellas Pharma US Inc1$20
Bristol Myers Squibb1$19
Upsher-smith Laboratories LLC1$19
Xeris Pharmaceuticals, Inc.1$18
SK Life Science, Inc.1$16
Mayne Pharma Commercial LLC1$16
Collegium Pharmaceutical, Inc.1$16
Neurelis, Inc.1$12
EMD Serono, Inc.1$12
Impel Pharmaceuticals Inc.1$12
Phathom Pharmaceuticals, Inc.1$3

How this compares

$9,939 in reported general payments places this provider in the 95th percentile of 80 primary care providers in Kentucky.

See all primary care providers in Kentucky →

Medicare billing

Part B allowed, 2024
$19,707
Medicare patients
91
Services billed
410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other primary care in Bowling Green

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →